Catalyst Funds Management’s Aldeyra Therapeutics ALDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-13,100
| Closed | -$65.4K | – | 461 |
|
|
2024
Q4 | $65.4K | Buy |
13,100
+12,500
| +2,083% | +$62.4K | 0.02% | 276 |
|
|
2024
Q3 | $3.23K | Buy |
+600
| New | +$3.23K | ﹤0.01% | 1255 |
|
|
2024
Q2 | – | Sell |
-4,760
| Closed | -$15.6K | – | 1158 |
|
|
2024
Q1 | $15.6K | Buy |
+4,760
| New | +$15.6K | ﹤0.01% | 815 |
|